Dingzi Yin

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Incapacitated Capicua in Sorafenib-Resistant HCC”.

Incapacitated Capicua in Sorafenib-Resistant HCC

Cellular and Molecular Gastroenterology and Hepatology(2020)10.1016/j.jcmgh.2020.03.007

N/A

0DataRank · unranked

4 citations

Kirk J. Wangensteen, Dingzi Yin

A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23

Gastroenterology(2023)10.1053/j.gastro.2023.02.043

N/A

0DataRank · unranked

69 citations

Dingzi Yin, Naoto Kubota, Xiaobo Wang, Aveline Filliol, Helen Remotti +7 more

Lipid Nanoparticle Delivery of Small Proteins for Potent In Vivo RAS Inhibition

ACS Applied Materials & Interfaces(2023)10.1021/acsami.3c01501

N/A

0DataRank · unranked

46 citations

Alexander Chan, Margaret M. Billingsley, Ningqiang Gong, Marshall S. Padilla, Emily H. Kim +6 more

In Vivo CRISPR Activation Screening Reveals Chromosome 1q Genes VPS72, GBA1, and MRPL9 Drive Hepatocellular Carcinoma

Cellular and Molecular Gastroenterology and Hepatology(2025)10.1016/j.jcmgh.2025.101460

N/A

0DataRank · unranked

6 citations

Chunmiao Cai, Markcus Lee, Dingzi Yin, Marie-Lise Chrystostome, Adrienne F. Gefre +4 more